MOLECULIN BIOTECH INC's ticker is MBRX and the CUSIP is 60855D101. A total of 22 filers reported holding MOLECULIN BIOTECH INC in Q1 2020. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2020 | $55,000 | +323.1% | 90,062 | +556.3% | 0.00% | – |
| Q4 2019 | $13,000 | -38.1% | 13,722 | -32.1% | 0.00% | – |
| Q4 2018 | $21,000 | -12.5% | 20,204 | +50.4% | 0.00% | – |
| Q2 2018 | $24,000 | +14.3% | 13,435 | +18.7% | 0.00% | -100.0% |
| Q4 2017 | $21,000 | -85.4% | 11,319 | -85.3% | 0.00% | -96.3% |
| Q2 2017 | $144,000 | +414.3% | 76,945 | +218.5% | 0.03% | +440.0% |
| Q1 2017 | $28,000 | – | 24,160 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Whitegate Investment Counselors, Inc. | 101,781 | $81,000 | 0.01% |
| Levy Wealth Management Group, LLC | 14,036 | $11,000 | 0.01% |
| WOODMONT INVESTMENT COUNSEL LLC | 12,000 | $10,000 | 0.00% |
| Renaissance Technologies | 948,503 | $756,000 | 0.00% |
| Qube Research & Technologies Ltd | 132,238 | $105,000 | 0.00% |
| Core Wealth Advisors, Inc. | 1,711 | $1,000 | 0.00% |
| UBS Group AG | 36,726 | $29,000 | 0.00% |
| IFP Advisors, Inc | 0 | $0 | 0.00% |
| Squarepoint Ops LLC | 12,342 | $10,000 | 0.00% |
| TRUE Private Wealth Advisors | 2,500 | $1,000 | 0.00% |